Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Chad Colon

Clinical Cardiac Electrophysiology Birmingham, AL Medical Doctor

NPI 1205299468 CMS profile 4871985

3980 Colonnade Pkwy, Birmingham, AL 35243

Open in the dashboard

General payments

$42,498

114 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Chad Colon of Birmingham, AL is reported in the CMS Open Payments database as having received $42,498 across 114 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 71st percentile of Clinical Cardiac Electrophysiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,784 45
2024 General $2,438 30
2023 General $23,724 18
2022 General $13,191 18
2021 General $190 1
2019 General $173 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Chad Colon
  • Clinical Cardiac Electrophysiology median
  • Middle half of Clinical Cardiac Electrophysiology
  • National median

In program year 2025, general payments to Chad Colon were reported at $2,784. Among 3,064 Clinical Cardiac Electrophysiology profiles paid that year, the median was $2,462 and the middle half received between $733 and $7,710.

Show as a table
Year Chad Colon Clinical Cardiac Electrophysiology median Middle half National median
2019 $173 $2,361 $585–$8,260 $163
2020 $0 $993 $247–$4,351 $114
2021 $190 $1,185 $326–$4,739 $132
2022 $13,191 $2,073 $554–$6,789 $149
2023 $23,724 $2,568 $759–$8,159 $160
2024 $2,438 $2,557 $703–$7,403 $164
2025 $2,784 $2,462 $733–$7,710 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $16,911 10 payments
  2. Boston Scientific Corporation $11,929 23 payments
  3. Abbott Laboratories $10,732 35 payments
  4. Biosense Webster, Inc. $2,753 37 payments
  5. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $86 4 payments
  6. Cardiva Medical, Inc. $45 2 payments
  7. Janssen Pharmaceuticals, Inc $22 1 payment
  8. Aziyo Biologics, Inc. $19 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Grant $34,667 9 payments
  2. Food and Beverage $6,293 97 payments
  3. Education $909 6 payments
  4. Travel and Lodging $630 2 payments
Products named General payments · program years 2019–2025
  1. S-ICD System Magnet $5,000 1 payment
  2. Carto 3 $2,595 35 payments
  3. ENSITE PRECISION $1,446 24 payments
  4. FARAPULSE $463 4 payments
  5. WATCHMAN Access System $401 5 payments
  6. Micra $277 3 payments
  7. ENSITE $205 1 payment
  8. EnSite Precision Cardiac Mapping System $190 1 payment
  9. EMBLEM MRI S-ICD $177 2 payments
  10. QUADRA ASSURA $160 1 payment
  11. Other $1,137 22 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 4 drugs

Part D claims

90

Median for Cardiology: 2,533

Drug cost

$27,218

Median for Cardiology: $485,213

Branded share of claims

26.7%

Median for Cardiology: 25.7%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 24 $26,363
Metoprolol Succinate Generic 30 $534
Amiodarone Hcl Generic 21 $276
Pantoprazole Sodium Generic 15 $44

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,782 Part D prescribers listed as Cardiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 55 billing codes

Paid by Medicare

$121,825

Medicare's payments for the services billed

Medicare patients

665

Average age 79

Services billed

1,889

334 women, 331 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Atrial fibrillation 70%
Ischemic heart disease 65%
Heart failure 58%
Arthritis 57%
Chronic kidney disease 50%
Diabetes 45%
COPD 31%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

114 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Clinical Cardiac Electrophysiology in Alabama

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record